About Nemosia
Nemosia is a company based in Winterthur (Switzerland) founded in 2020. Nemosia has raised $164.55 thousand across 1 funding round from investors including Venture Kick. Nemosia offers products and services including PET Tracer for NMDA Receptor and 18 F-OF-NB1. Nemosia operates in a competitive market with competitors including Rhenovia Pharma, Afraxis, Wave Neuro, Neuro-Sys and Cerca Insights, among others.
- Headquarter Winterthur, Switzerland
-
Sectors
Healthcare
-
Phone
Locked
-
Website
Locked
-
Social
Locked
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Total Equity Funding
$164.55 K (USD)
in 1 rounds
-
Latest Funding Round
$164.55 K (USD), Seed
Aug 30, 2021
- Investors
-
Employee Count
Not available
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Nemosia
Nemosia offers a comprehensive portfolio of products and services, including PET Tracer for NMDA Receptor and 18 F-OF-NB1.
Radioactive molecule for PET scans to detect brain neurodegeneration early.
Synthesized tracer evaluated for NMDA receptor imaging in non-human primates.
Funding Insights of Nemosia
Nemosia has successfully raised a total of $164.55K through 1 strategic funding round. The most recent funding activity was a Seed round of $164.55 thousand completed in August 2021. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
Investors in Nemosia
Nemosia has secured backing from 1 investor, including venture fund investors. Prominent investors backing the company include Venture Kick.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
University backed startup accelerator
|
Locked | Locked | Locked |
Investor details for Nemosia
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Nemosia
Investment portfolio details for Nemosia
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Nemosia
Detailed financials for Nemosia
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Nemosia Comparisons
Peer comparison for Nemosia
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Nemosia
Nemosia operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Rhenovia Pharma, Afraxis, Wave Neuro, Neuro-Sys and Cerca Insights, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Biosimulation technology is provided for CNS drug discovery and development.
|
|
| Locked | Locked | Locked |
Provides comprehensive CNS pharmaceutical screening technologies for pre-clinical evaluations.
|
|
| Locked | Locked | Locked |
Preclinical services to neurological science are provided.
|
|
| Locked | Locked | Locked |
Preclinical CRO services for neurodegenerative diseases are offered by Neuro-Sys.
|
|
| Locked | Locked | Locked |
Provides preclinical services in behavioral pharmacology for research and development.
|
|
| Locked | Locked | Locked |
Provider of in vivo and ex vivo services to drug developers for neurological disorders
|
Detailed competitors of Nemosia
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Nemosia
Complete news archive for Nemosia
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Nemosia
Nemosia was founded in 2020 and raised its 1st funding round 1 year after it was founded.
Nemosia is headquartered in Winterthur, Switzerland. It is registered at Winterthur, Zurich, Switzerland.
Nemosia is a funded company, having raised a total of $164.55K across 1 funding round to date.
Nemosia was founded in 2020 and is based in Winterthur, Switzerland. Preclinical services are delivered by the company in the neuroscience sector, focusing on neurological disorders. Early-stage research and testing for potential therapies are supported through these operations. The domain nemosia.com is utilized for online presence. Activities are centered on preclinical development to aid pharmaceutical and biotech advancements in the region.
Nemosia's top competitors include Brains On-Line, Neuro-Sys and Rhenovia Pharma.
Nemosia offers PET Tracer for NMDA Receptor and 18 F-OF-NB1.
Nemosia has 1 investor. Key investors include Venture Kick.